Edgar G. Engleman's most recent trade in Bolt Biotherapeutics Inc was a trade of 25,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 10, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bolt Biotherapeutics Inc | Edgar G. Engleman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Bolt Biotherapeutics Inc | Edgar G. Engleman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Bolt Biotherapeutics Inc | Edgar G. Engleman | Director, Ten Percent Owner | 09 Feb 2021 | 1,092,080 | 1,117,184 | - | - | Common Stock | ||
| Bolt Biotherapeutics Inc | Edgar G. Engleman | Director, Ten Percent Owner | 09 Feb 2021 | 1,092,080 | 0 | - | - | Series B Preferred Stock | ||
| Bolt Biotherapeutics Inc | Edgar G. Engleman | Director, Ten Percent Owner | 09 Feb 2021 | 345,568 | 1,780,674 | - | - | Common Stock | ||
| Bolt Biotherapeutics Inc | Edgar G. Engleman | Director, Ten Percent Owner | 09 Feb 2021 | 345,568 | 0 | - | - | Series C- 2 Preferred Stock | ||
| Bolt Biotherapeutics Inc | Edgar G. Engleman | Director, Ten Percent Owner | 09 Feb 2021 | 317,922 | 1,435,106 | - | - | Common Stock | ||
| Bolt Biotherapeutics Inc | Edgar G. Engleman | Director, Ten Percent Owner | 09 Feb 2021 | 317,922 | 0 | - | - | Series C- 1 Preferred Stock | ||
| Bolt Biotherapeutics Inc | Edgar G. Engleman | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 20.00 per share. | 09 Feb 2021 | 175,733 | 1,997,216 | - | 20 | 3,514,660 | Common Stock |
| Bolt Biotherapeutics Inc | Edgar G. Engleman | Director, Ten Percent Owner | 09 Feb 2021 | 150,802 | 154,268 | - | - | Common Stock | ||
| Bolt Biotherapeutics Inc | Edgar G. Engleman | Director, Ten Percent Owner | 09 Feb 2021 | 150,802 | 0 | - | - | Series B Preferred Stock | ||
| Bolt Biotherapeutics Inc | Edgar G. Engleman | Director, Ten Percent Owner | 09 Feb 2021 | 47,718 | 245,887 | - | - | Common Stock | ||
| Bolt Biotherapeutics Inc | Edgar G. Engleman | Director, Ten Percent Owner | 09 Feb 2021 | 47,718 | 0 | - | - | Series C- 2 Preferred Stock | ||
| Bolt Biotherapeutics Inc | Edgar G. Engleman | Director, Ten Percent Owner | 09 Feb 2021 | 43,901 | 198,169 | - | - | Common Stock | ||
| Bolt Biotherapeutics Inc | Edgar G. Engleman | Director, Ten Percent Owner | 09 Feb 2021 | 43,901 | 0 | - | - | Series C- 1 Preferred Stock | ||
| Bolt Biotherapeutics Inc | Edgar G. Engleman | Director, Ten Percent Owner | 09 Feb 2021 | 40,953 | 1,821,627 | - | 0.1 | 2,867 | Common Stock | |
| Bolt Biotherapeutics Inc | Edgar G. Engleman | Director, Ten Percent Owner | 09 Feb 2021 | 40,953 | 0 | - | - | Warrant (Right to Buy) | ||
| Bolt Biotherapeutics Inc | Edgar G. Engleman | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 20.00 per share. | 09 Feb 2021 | 24,267 | 275,789 | - | 20 | 485,340 | Common Stock |
| Bolt Biotherapeutics Inc | Edgar G. Engleman | Director, Ten Percent Owner | 09 Feb 2021 | 5,655 | 251,542 | - | 0.1 | 396 | Common Stock | |
| Bolt Biotherapeutics Inc | Edgar G. Engleman | Director, Ten Percent Owner | 09 Feb 2021 | 5,655 | 0 | - | - | Warrant (Right to Buy) | ||
| Bolt Biotherapeutics Inc | Edgar G. Engleman | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 09 Feb 2021 | 144 | 1,821,483 | - | 20 | 2,880 | Common Stock |
| Bolt Biotherapeutics Inc | Edgar G. Engleman | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 09 Feb 2021 | 20 | 251,522 | - | 20 | 400 | Common Stock |